Ekso Bionics to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

RICHMOND, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Investors interested in listening to the conference call may do so by dialing [phone] for domestic callers or [phone] for international callers. A live webcast of the event will be available in the “Investors” section of the company’s website at www.eksobionics.com, or by clicking here.

A replay of the call will be available for two weeks by dialing [phone] for domestic callers or [phone] for international callers and using Conference ID: 13698960.  The webcast will also be available on the company’s website for one month following the completion of the call.

About Ekso Bionics

Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
[e-mail]

Media Contact:
Carrie Yamond Mas
917-371-2320
[e-mail]